Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Published in: Reactions Weekly 1/2013

01-12-2013 | Case report

Sulprostone

First report of tako-tsubo cardiomyopathy: case report

Published in: Reactions Weekly | Issue 1/2013

Login to get access

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
  • * First published case report
…
Literature
Courand PY, et al. Tako-tsubo cardiomyopathy probably associated with administration of sulprostone following cesarean delivery. Revista Espanola de Cardiologia 65: 770-771, No. 8, Aug 2012 - FrancePubMedCrossRef
Metadata
Title
Sulprostone
First report of tako-tsubo cardiomyopathy: case report
Publication date
01-12-2013
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2013
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-013-7809-9

Other articles of this Issue 1/2013

Reactions Weekly 1/2013 Go to the issue

Case report

Peginterferon-α-2a/peginterferon-α-2b

Case report

Ipilimumab

Case report

Bevacizumab

Case report

Botulinum toxin A

News item

Project aims to advance vaccine benefit:risk assessment in Europe

Case report

Cefepime/phenytoin